

Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|14|14|1667-1674
ISSN: 1389-4501
Source: Current Drug Targets, Vol.14, Iss.14, 2013-12, pp. : 1667-1674
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab
Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. :



